Glycyltyrosine
Also known as: Gly-Tyr, Glycyl-L-tyrosine, H-Gly-Tyr-OH
Summary
Glycyltyrosine is a simple dipeptide consisting of glycine linked to tyrosine. It is not approved as a therapeutic agent and is used principally as a biochemical reagent, enzyme substrate, and research reference compound. It is a substrate for various peptidases and aminopeptidases and has been used in studies of peptide transport and enzyme kinetics.
Mechanism of Action
Glycyltyrosine (Gly-Tyr) is a naturally occurring dipeptide composed of glycine and tyrosine. It serves primarily as a biochemical substrate and reference compound; it can be hydrolyzed by peptidases to release free glycine and tyrosine, contributing to amino acid pools. It has low intrinsic pharmacological activity and is used mainly as a biochemical reagent and research tool.
Routes of Administration
No administration routes recorded yet.
Goals & Uses
- Biochemical research substrateResearchModerate
- Peptide transport studiesResearchLow
Contraindications
No contraindications recorded yet.
Adverse Effects
No adverse effects recorded yet.
Drug Interactions
No drug interactions recorded yet.
Population Constraints
No population constraints recorded yet.
Regulatory Status
- European UnionUnapprovedNot approved by EMA; used only as a research reagent.
- United StatesUnapprovedNot approved by FDA; used only as a research reagent.
Not approved by any regulatory agency as a drug or therapeutic product. Used as a research reagent and biochemical reference standard. No clinical indication established.
Evidence & Sources
No sources recorded yet.